Report overview
Ligand binding assays (LBA) are analytical procedures to quantify an analyte (macromolecule) based on its affinity for a ligand, including but not limited to antibodies, antigens, receptors, oligonucleotides and peptides.
This report aims to provide a comprehensive presentation of the global market for Ligand Binding Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ligand Binding Assay. This report contains market size and forecasts of Ligand Binding Assay in global, including the following market information:
Global Ligand Binding Assay Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Ligand Binding Assay market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Radioactive Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ligand Binding Assay include Sygnature Discovery, Shanghai Medicilon Inc, Intertek Group plc, PerkinElmer Inc, Charles River, Alliance Pharma, Eurofins Discovery, Creative Biogene and IBR Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ligand Binding Assay companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ligand Binding Assay Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Ligand Binding Assay Market Segment Percentages, by Type, 2022 (%)
Radioactive
Non-radioactive
Global Ligand Binding Assay Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Ligand Binding Assay Market Segment Percentages, by Application, 2022 (%)
Biomedical Research
Drug Discovery
Others
Global Ligand Binding Assay Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Ligand Binding Assay Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ligand Binding Assay revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Ligand Binding Assay revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sygnature Discovery
Shanghai Medicilon Inc
Intertek Group plc
PerkinElmer Inc
Charles River
Alliance Pharma
Eurofins Discovery
Creative Biogene
IBR Inc
LGC Limited
Accelero Bioanalytics GmbH
Gifford Bioscience Limited
GE Healthcare
Antigen Discovery Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ligand Binding Assay, market overview.
Chapter 2: Global Ligand Binding Assay market size in revenue.
Chapter 3: Detailed analysis of Ligand Binding Assay company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ligand Binding Assay in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
